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ABSTRACT
L-cell colony-stimulating factor (CSF) is identical to macrophage growth factor
and stimulates macrophage proliferation (Stanley et al ., 1976, J . Exp. Mea . 143:
631-647) . The nature of the interaction of iodinated L-cell CSF (1251_CSF) with
murine peritoneal exudate macrophages was studied . On incubation with 10 pM
1251-CSF at 0°C, cellular binding of 125I-CSF reaches a stable maximum within 15
h . This is in contrast to the association behavior at higher temperatures . At 37 °C,
cell-associated 1251-CSF levels reach, within 45 min, an unstable maximum which
is up to 10-fold less than that occurring under the same conditions at 0°C . At 0 °C,
binding is saturated (-5 x 104 sites/cell) at CSF concentrations of 1 nM . A
comparison of binding and competition experiments indicates that iodinated L-
cell CSF binds as effectively as L-cell CSF and that human urinary CSF and L-
cell CSF equipotently compete for 1251-CSF binding . Specificity of the CSF-
binding site is demonstrated by the failure of other known growth factors and
hormones to compete for 1251-CSF binding. These studies and other findings
suggest that
1251-CSF binding is restricted to macrophages and their precursors
and to macrophage cell lines and that the binding site(s) is the receptor mediating
the biological action of this CSF .
Colony-stimulating factors (CSFs) are growth fac-
tors that are required for granulocyte and macro-
phage production from undifferentiated hemo-
poietic precursor cells in culture (2, 17, 26) . One
of these, a sialoglycoprotein of mol wt 70,000, has
been purified from mouse L-cell conditioned me-
dium (27) and is identical to macrophage growth
factor (25) . This particular factor belongs to the
CSF subclass stimulating only macrophage pro-
duction (23, 28) and will be, for convenience,
hence-forth referred to as CSF . As CSF is abso-
lutely required for the proliferation of both pe-
ripheral macrophages and their undifferentiated
precursor cells (24), the CSF-target cell system is
a potentially powerful one for studying the bio-
chemical effects of a growth factor on cellular
proliferation and differentiation .
The first step in the series of events leading to
CSF-induced macrophage proliferation should in-
volve the interaction ofCSF with its target cells.
MATERIALS AND METHODS
Reagents
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We here report the existence of a specific and
saturable CSF-binding site(s) on a relatively ho-
mogeneous population ofperitoneal exudate mac-
rophages . In addition, we present preliminary ev-
idence that the occurrence of this binding site(s) is
restricted to macrophages, their precursors, and
macrophage cell lines.
L-cell CSF was purified as previously described (27) . The
purity was checked by polyacrylamide gel electrophoresis, with
and without SDS, under reducing and nonreducing conditions,
and bycomplexing with rabbit anti-CSF antibody (27). The CSF
preparation was iodinated (one to two atoms ' 25 1 per molecule,
59,000 cpm/ng) with full retention of biological and antibody-
binding activities (23, 26, 27) . ' 251-CSF was used within 3 wk of
iodination as its biological activity decreases with time (half-life
-6 wk) . There is a close correlation between biological and
antibody-binding activities (23, 28), and the biologically active
' 251-CSF fraction can be rapidly determined as the fraction of
153'asl combining with excess rabbit anti-CSF antibody (23) . Mo-
larities of biologically active 1251-CSF were calculated from this
fraction and the protein concentration (11) determined using a
bovine serum albumin standard, assuming a mot wt of 70,000
(27) .
Partially purified (stage VI)human urinaryCSFwas prepared
as previously described (26, 28). Purified preparations of nerve
growth factor (NGF) and epidermal growth factor (EGF) (mouse
submaxillary glands), fibroblast growth factor (FGF) (bovine
pituitary glands), and multiplication stimulating activity (MSA)
(Buffalo rat liver cell conditioned medium) were gifts from
Collaborative Research Inc . (Waltham, Mass .) . Purified human
urinary erythropoietin (l3) was a gift of Dr . E . Goldwasser .
Hormone preparations usedwere recrystallizedbovine pancreatic
insulin (Calbiochem-Behring Corp ., American Hoechst Corp .,
San Diego, Calif .), crystalline bovine and porcine pancreatic
glucagon (Sigma Chemical Co., St . Louis, Mo .), sheep pituitary
luteotropic hormone (LH) (26 IU/mg, Sigma Chemical Co .),
porcine pituitary somatotropin(0 .4 U/mg, Sigma Chemical Co .),
porcine follicle-stimulating hormone (FSH) (2 U/mg, Sigma
Chemical Co .), and synthetic adrenocorticotropic hormone
(ACTH) (Cortrosyn, Organon Inc., West Orange,N. J.) .
Bioassay
CSF bioassays were carried out using murine bone marrow
cells as described previously (12, 25).
Target Cells
Peritoneal exudate macrophages were prepared from 3 mo-
old C3H/Anfmice that had received 3 d previously an intraper-
itoneal injection of 1.5 ml of 2% hydrolyzed starch (Connaught
Laboratories, Toronto, Canada) in PBS (0.15 M NaCl, 0.005 M
phosphate, pH 7.35) . Cells were collected from the peritoneal
cavity in 10 ml of a medium (Kansas City Biological, Kansas
City, Mo.) containing 0.025 M HEPES(Grand Island Biological
Co., Grand Island, N . Y.) in lieu of bicarbonate, pH 7.35, at
23'C (a-HEPES) made 10% (vol/vol) in fetal calf serum (FCS)
(Flow Laboratories, Inc., Rockville, Md.) (FCS-a-HEPES), and
5 U/ml in heparin (Upjohn Co., Agricultural Prods MKT,
Kalamazoo, Mich .) . They were washed once by centrifugation
(800 g, 10 min) in 10 ml of a-HEPES, and 10 6 cells in 2 ml of
FCS-a-HEPES was incubated in 35-mm tissue culture dishes
(Lux Scientific Corp ., Newbury Park, Calif.) for 15-20 min at
37°C . The medium was swirled to loosen cells not firmly at-
tached, and the supernatant fluid was aspirated . The adherent
cells were washed once with amedium (2 ml/dish) and incubated
fora15 h in 10% FCS (vol/vol) in a medium (FCS-a) at 37°C
in a humidified, 10% C02 in air atmosphere before 12 '51-CSF-
binding studies . 100% of these cells are capable of Fc-mediated
phagocytosis of antibody-coated sheep erythrocytes (5) . Unstim-
ulatedor "resident" peritoneal macrophages were harvested from
untreatedC3H/Anfmice and plated as described above except
that the adherent cells were allowed 2 h for attachment rather
than 15 min . Bone marrow cells were obtained by gently aspir-
ating the bone marrow plugs from trimmed femoral shafts of
C3H/Anf mice through a 22-gauge needle into FCS-a-HEPES .
Tissue clumps were allowed to settle, and the supernatant cell
suspension was diluted to 10' nucleated cells/ml for 1251-CSF-
binding studies . Themouse myeloma cell line MOPC-21 (8) and
the myeloma-macrophage hybrid line FC-I (5) were supplied by
Dr.B. Diamond ; the mouse macrophage lines 7774 .2 and7774.16
(5, 20) were provided by Dr. B . Bloom ; the mouse Friend
erythroleukemic line DS19 (15) by Dr . C. Schildkraut; the LcE9
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rat myoblast cells (14) by Dr . B . Nodal-Ginard ; the Chinese
hamsterovary cells (l8) by Dr . P . Stanley; theM I mouse myeloid
leukemia line (9) by Dr . D. Housmaw themouse lines WEHI-3,
P388D1, PU5-1 .8, and RAW264 (19) by Dr. P . Ralph; and the
mouse 3T3-LI cells (7) by Dr . O Rosen .
Determination of Cell-associated
1281
After incubation for 15 h in FCS-a without CSF, adherent
cells on 35-mm tissue culture dishes were washed once with PBS
and 0.9 ml of FCS-a-HEPES, or, in some cases, 10% dialysed
FCS in PBSwasadded . The cells were brought to the appropriate
temperature before addition of 0.1 ml of the same medium
containing '2"I-CSF or ' 251-CSF plus competing unlabeled CSF,
hormones, or growth factors . Incubations were carried out in a
humidified atmosphere at the appropriate temperature . The re-
action was stopped by 4 x 2.5 ml washes ofice-cold PBS and the
cells were either instantly fixed in situ with cold methanol (for
staining or autoradiography) or solubilized from the dishes with
3 x 0.5 ml washes of 0.05M Tris-HCI, 0.5% SDS, pH 7.4' (for
gamma counting) . Cell numbers were determined from counts of
20 randomly selected fields on methanol-fixed, Giemsa-stained
dishes . For '2'I-CSF-binding studies with nonadherent cells, the
cells were incubated for at least4 h in FCS-a (without CSF at
37 °C), washed once with PBS (800 g, 10 min, 2°C), resuspended
to 1 .1 x 10 6 cells/ml in FCS-a-HEPES, cooled to 0°C, and 0.9
ml was aliquoted into cold 35-mm plastic petri dishes (Falcon
Lobware, Div . of Becton, Dickinson & Co., Oxnard, Calif.) .
Incubations with "'I-CSF were carried out as for the adherent
cells . The reaction was stopped by layering the cell suspension
over 3 ml of ice-cold FCS in a 5-ml culture tube (Falcon No .
2054) and centrifuging (800 g, 10 min, 2°C) . While the pellet
was kept at 4°C, the supernatant fluid was aspirated away . The
cell pellets were either counted in a gamma counter or resus-
pended in ice-cold FCS, spun onto ice-cold slides in a cooled
cytocentrifuge (Shandon Southern Instruments Inc ., Sewickley,
Pa.), and fixed in cold methanol for autoradiography (25) . After
development, the emulsion-covered cells were stained with
Giemsa or Wright's stain in 0.1 M citrate, pH 5.75 .
RESULTS
Thetime andtemperaturedependence of 1251 bind-
ing' by peritoneal exudate macrophages in the
presence of 10 pM 1251-CSF is shown in Fig. I .
Maximal 1251 bound by the cells is some 10 times
greater at 0° than at 37°C . At 0°C, a stable
maximum level ofbound 1251 is achieved. In con-
trast, a stable maximal equilibrium is not reached
at 22° or 37°C . The decrease in cell-associated 1251
at 37°C after maximal levels have been reached
cannot be explained by the much slower decrease
in the supernatant concentration of biologically
active 1251-CSF because of binding site mediated
1251-CSF destruction (28) . Preliminaryexperiments
' This treatment removes all 'zr 'I counts from the dishes .
2 1251 binding refers to total cell-associated
'2 .I after in-
cubation with '251-CSF as described in Materials and
Methodsanddoesn't distinguish between surface-bound
and internalized 125 1 .E
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FIGURE I
￿
Kinetics of binding of 1251-CSF (l0 pM) by
murine peritoneal exudate macrophages at 0° (O), 22°
(0), and 37°C (A) . Data are normalized to present '251
binding in cpm/105 cells . Open symbols represent total
binding of 1251 and filled symbols the binding in the
presence of I nM unlabeled CSF . Details are given in
the text .
indicate that the decrease from maximal levels of
binding with time at higher temperatures is caused
by changes in the ability of the cells to bind
1251-
CSF combined with a loss of cell-associated 1251 .
Immediately after exposure of 1251-CSF to cells at
37°C, their ability to continue to bind 1251_CSF is
rapidly lost and remains absent for the next few
hours. Concomitantly the 1251-CSF which has
bound is degraded to TCA-soluble 1251 and re-
leased causing an observed net loss (data not
shown) . Similar behavior is observed in the inter-
action of 1251-EGF with human fibroblasts (4).The
proportion of the 1251 binding which is competed
for by a 50-fold excess ofunlabeled CSF (specific
binding) is larger at 0° (98%) than at 37°C (89%) .
Because 1251 binding at 0°C reaches a stable
maximum with the highest proportion of compet-
able to total binding, studies on saturability and
specificity were carried out at 0°C . Under these
conditions, stable equilibrium levels are attained
in <_20h (at ?2 pM 1251-CSF), at which time >95%
of the cells were viable as assessed by trypan blue
exclusion . 1251 binding by peritoneal exudate mac-
rophages at 0 °C saturates at <10-9M (Fig . 2) . A
Scatchard plot (21) of these binding data (Fig . 2,
inset) is linear over the free 1251-CSF concentration
range 8 x 10-13 to 2 x 10-1°M . From this plot the
calculated equilibrium constant for 1251-CSF-bind-
ing site dissociation (K,2 :;1.CSF = 1/slope) is 1 .1 x
10-11 M, and the number of sites per cell, calcu-
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FIGURE 2
￿
' 251-CSF bound to peritoneal exudate mac-
rophages at 0°C as a function of the concentration of
free 1251-CSF at equilibrium . Both total binding (O and
binding in the presence of a 50x excess of unlabeled
CSF (") has been normalized to cpm per 105 cells.
(Experimental cell concentration was 2.55 x 105 cells/
ml .) Inset: Data plotted according to the method of
Scatchard (2 l) . Abscissa: Bound 125 I-CSF concentration
in picomoles per liter . Ordinate : Ratio of bound to free
125
1-CSF (unitless) .
lated from the abscissa intercept, is 52,000 . The
values of K1251.CSF calculated from the slope of the
Scatchard plot and from the ratio of the initial
dissociation rate constant to the initial association
rate constant agree ; however, only 10-20% of the
bound 1251-CSF dissociates at 0° .s We have no
explanation at present for the partial reversible
nature of the interaction or its effect on the inter-
pretation of the Scatchard plot .
The specificity ofthe 1251-CSF-binding site(s) on
macrophages for CSF was established by testing
the ability ofknown hormones andgrowth factors
to compete with 1251-CSF for binding at 0°C (Fig .
3) . In the concentration range 10-12 to 10-s M,
only purified mouse L-cell CSF and partially pu-
rified human urinary CSF (26, 28) compete with
1251-CSF (2 pM) for binding . Equivalent concen-
trations (in bioactivity units/ml)ofhuman urinary
CSF and mouse L-cell CSF compete equivalently
for mouse 1251-CSF binding . The relationship be-
tween the unlabeled CSF concentration at 50%
inhibition (-1.8 x 10-11 M, Fig . 3) and the appar-
ent dissociation constants for 1251-CSF (K1251_CSF =
' Guilbert, L . J ., and E . R. Stanley . The nature of the
interaction of 1251-CSF with macrophages. Manuscript in
preparation .
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FIGURE 3
￿
Competition for 'z5I-CSF binding to perito-
neal exudatemacrophages by unlabeledCSFs and other
growth factors and hormones . Incubations were carried
out for 20 h at 0°C in the presence of 2 pM 1251_CSF and
5.9 x 10 ° macrophages/ml. Abscissa: Upper scale (molar
concentration) applies to all competing agents except
human urinary CSF, and lower scale (bioactivity units/
ml) applies only to mouse L-cell and human urinary
CSF . Ordinate : Percent of control binding = 100 x cpm
bound in presence ofcompeting agent - cpm bound in
absence ofcompeting agent . Competingagents are: (solid
lines) EGF (A), erythropoietin ("), insulin (O), glucagon
(0), NGF ("),MSA (O),ACTH ("), FGF (x) ; (broken
lines) mouse L-cell CSF (O), and human urinary CSF
1.1 X 10-11 M) and CSF (KcsF, unknown) is given
by Eq. 1 (10) :
[CSF]so% = KosF +
(1)
(KCSF/K .25I.CSF) . ([
125I-CSF]o + Ro - 3/2 B) .
For the competition curve shown in Fig . 3,
['z5I-
CSF]o (total 'z5I-CSF) = 2 x 10- ' z M, Ro (total
binding site concentration, calculated from the
No . of cells/ml) = 5.1 x 10-'z M, and B (concen-
tration of bound IzSI-CSF in the absence of com-
peting CSF) = 5.8 x 10- 's M (data not shown) .
Solving Eq. 1 for KosF gives 1.2 x 10-"M. With
the reasonable assumption that the partial revers-
ibility of the CSF-macrophage interaction affects
the outcome of K1LSLCSF and KosF calculations
equally, it appears that IzSI-CSF and unlabeled
CSF have the same affinity for acommon binding
site(s) . This observation is in accord with the ob-
served complete retention of biological activity
after iodination ofCSF .
The other hormones and growth factors tested
(Fig . 3), including somatotropin (10-z U/ml), LH
(l00 IU/ml), andFSH (5 U/ml) (data not shown),
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failed to compete . In addition, as there was no
difference in the degree of specific 'z5I-CSF bind-
ing for incubations in a-HEPES, FCS-a-HEPES,
or PBS containing EDTA (3 mM) and dialysed
FCS" (10% vol/vol) (data not shown), binding is
not competed for by serum components, e.g., gly-
coproteins (1, 22) or lipoproteins (6), or influenced
by Ca". Binding of CSF (a glycoprotein) is not
mediated "nonspecifically" by the mannosyl-glu-
cosyl-binding site found on some macrophage
populations (22) because 'z5I-CSF binding is not
affected by yeast mannan (1 mg/ml) (data not
shown) . Furthermore, the mannosyl-glucosyl-
binding site and the galactose-specific recognition
site for glycoprotein uptake have been reported to
be absent from peritoneal exudate macrophages'
To determine whether the occurrence of CSF-
binding sites is restricted to particular cell types,
CSF binding by various primary cells and contin-
uous cell lines was studied . In the case of the
primary cell populations examined, binding by
"resident" peritoneal macrophages was '/3, and
binding by bone marrow cells was I/soo, of the
amount boundby peritoneal exudatemacrophages
(Table I) . To determine whether the lower degree
of binding exhibited by both resident peritoneal
macrophages and bone marrow cells was caused
by a decrease in the average amount of 'z5I-CSF
bound per cell or to a lower frequency of binding
cells, all primary cell populations examined were
subjected to autoradiography. In autoradiographs,
>98% of peritoneal exudate macrophages incu-
bated with IS pM IzSI-CSF at 0°C for 15 h had
>20 grains associated with them (Fig . 4a) in con-
trast to cells incubated under the same conditions
with 'z5I-CSF plus a 50-fold excess of unlabeled
CSF, 100% of which had less than five grains per
cell . Autoradiographs show that the lowerbinding
by resident peritoneal macrophages is caused by
a lower average amount of 'z5I-CSF bound per
cell rather than by a lowered frequencyofbinding
cells (data not shown). In contrast, the very low
binding of 1251-CSF by bone marrow cells (on an
average per cell basis) is explained by the autora-
Even experiments carried out in the presence of 50%
(vol/vol) FCS showed little loss in specific 1251_CSF
binding (data not shown) . Although FCS likely has some
bovine CSF activity, the lot used here was selected for
the absence ofactivity in the murine bioassay .
Stahl, P ., Washington University School of Medicine,
St . Louis . Personal communication .TABLE I
' 257-CSF Binding by Various Rodent Cell Types at
0°C
' Unless otherwise indicated, cells are of murine origin .
$The binding experiments were carried out at 15 pM
' 251-CSF . Specifically bound 1251-CSF represents the
binding that is competed for by l nM unlabeled CSF .
§ Incubations as described in text for nonadherent cells.
diographic observation that only 6% of the cell
population binds 1251-CSF and that the average
amount bound by this binding fraction is much
lower (<10%) than the average amount bound by
peritoneal exudate macrophages . Greater than
90% of these CSF-binding cells were mononuclear
and appeared to be macrophages, monocytes, or
undifferentiated cells (monoblasts) (Fig . 4b) .
Fewer than 10% of the CSF-binding cells had the
typical ring-shaped nucleus ofan immature mouse
granulocyte (Fig. 4b) . However, most cells with
ring-shaped nuclei were unlabeled, raising the
question of whether the labeled fraction is indeed
comprised of granulocyte (rather than macro-
phage) precursors . In this respect, recent reports of
the existence of mononuclearphagocytic cells with
ring-shaped nuclei are relevant (3, 16) . 1251 binding
by erythrocytes and recognizable erythroid cells,
megakaryocytes, and mature granulocytes could
not be detected .
A number of rodent cell lines were tested for
1251-CSF binding at 0°C (Table I) . Of the 14 lines
examined, six were positive : J774.2 and J774.16,
FC-1, P388D1, PU5-1 .8, and WEHI-3 . All are
macrophage or monocytic lines (19). However, the
macrophage line RAW264 and the myeloid leu-
FIGURE 4
￿
Autoradiographs of mouse peritoneal exu-
date macrophages and bone marrow cells which have
been incubated with 15 pM 1251_CSF for 15 h at 0°C. (a)
Peritoneal exudate macrophages. Exposure time 5 d,
stained with Giemsa. Bar, 25 [Lm. (b) Bone marrow cells .
Exposure time 22 d, stained with Wright-Giemsa. Right
inset : Labeled cell with ring-shaped nucleus . Left inset:
Labeled immature mononuclear cell. Arrows point to
labeled mature macrophages. Note unlabeled immature
granulocytes and erythroid cells . Bar, 10 pm .
kemic line M1 did not bind significant amounts of
'251-CSF .
DISCUSSION
The data indicate a highly specific and saturable
binding site for 1251-CSF on macrophages . We are
currently determining the nature (mononuclear
phagocytic or granulocytic) of the 1251-CSF-bind-
ing cells with ring-shaped nuclei. However, the
possibility that the CSF-binding site exists exclu-
sively on cells of the mononuclear phagocytic
system (29) is in accord with the observation that
this CSF subclass stimulates the formation of col-
onies containing only macrophages (28) . The pres-
ence of CSF-binding sites may well be a specific
marker for cells of this system .
Several characteristics of 1251_CSF binding to
RAPID COMMUNICATIONS
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Cell Type"
cpm Specifically bound/
10' cells$
Peritoneal exudate macrophages 23,500
Resident peritoneal macrophages 7,900
Nucleated bone marrow cells§ 44
P388D1 macrophage§ 3,500
J774 .2 macrophage 2,900
J774.16 macrophage 2,300
FC-1 macrophage-myeloma hybrid 1,600
WEHI-3 monocytic§ 650
PU5-1 .8 macrophage§ 540
RAW264 macrophage§ 0
M1 myeloid leukemic§ 40
MOPC-21 myeloma§ 10
DS19 erythroleukemic§ 0
L6E9 myoblast (rat) 42
CHO (hamster) 6
3T3-L1 fibroblast§ 0
L 929 fibroblast 0target cells suggest that the binding site is the
receptor through which the biological effects of
this CSF subclass are mediated. (a) Among the
cells examined, all those known to biologically
respond to this CSF possess the binding site . (b)
All the cells and cell lines which bind this CSF
belong to, or are derived from, the mononuclear
phagocytic line progression on which it specifically
(23) acts . (c) Competition for binding is exhibited
by this CSF subclass (human or murine), and the
degree of competition is directly related to the
biological activity of the competing preparation
on murine target cells . (d) Other CSF subclasses
that affect granulocyte production fail to compete
for binding.' (e) The CSF concentration necessary
for maximal stimulation of peritoneal exudate
macrophage colony formation is 100 pM (24) and
the serumCSF concentration in normalC3H/Anf
mice is 50 pM' (see footnote 4) . Both these con-
centrations fall on the ascending portion of the
0°C binding curve (Fig . 2) .
It is apparent that a variety of functionally
distinct cell types of mononuclear phagocytic ori-
ginare capable of specifically binding CSF . These
range from immature to mature mononuclear
phagocytes and include continuous cell lines .They
exhibit a spectrum of responses to CSF : some
(immature bone marrow cells and peritoneal exu-
date cells) have an absolute requirement for CSF
in order to proliferate (24); others (resident peri-
toneal macrophages) fail to proliferate in its pres-
ence (24) and the continuous cell lines proliferate
in the absence of added CSF. Because of the
variety of CSF binding cell types available, the
CSF-target cell system is an attractive model for
studying the effects of a growth factor on prolif-
eration and differentiation .
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